ALLMedicine™ Creatinine Clearance Center

Nov 28th, 2021 - Overcoming Vestiges of Structural Racism in Kidney Care and Renal Nutrition and Revisiting Cockcroft-Gault Creatinine Clearance and Its Weight Index.|2021|Kalantar-Zadeh K,Norris KC,Moore LW,|

Nov 28th, 2021 - To assess the impact of preoperative chronic kidney disease (CKD) on perioperative morbidity and mortality in a contemporary cohort undergoing renal surgery in an era of increased prevalence of minimally invasive surgery and partial nephrectomy. T...

Nov 24th, 2021 - The primary objective of this study aims to test patient factors, with a focus on cardiometabolic disease, influencing the performance of the Cockcroft-Gault equation in estimating glomerular filtration rate. A cohort study was performed using dat...

Nov 23rd, 2021 - Inflammation and oxidative stress are the major pathways involved in ischemia-reperfusion (I/R)-induced renal injury. This study was designed to evaluate the potential effect of pomegranate against I/R-induced renal injury. I/R injury was induced ...

Nov 23rd, 2021 - Resistant hypertension is highly prevalent among the general hypertensive population and the clinical management of this condition remains problematic. Different approaches, including a more intensified antihypertensive therapy, lifestyle modifica...

Aug 2nd, 2015 - The recent guideline for the evaluation and management of Chronic Kidney Disease recommends assessing GFR employing equations based on serum creatinine; despite this, creatinine clearance 24-hour urine collection is used routinely in many settings...

Nov 19th, 2021 - Prosthetic paravalvular leaks (PVL) are associated with congestive heart failure and haemolysis, for which the standard treatment is open-heart surgery with the attendant risks to the patient. Transcatheter closure has emerged as an alternative. P...

Oct 26th, 2021 - The mortality of acute renal failure (ARF) remains high despite advances in supportive care. There are no established effective drug therapies, and dialysis may promote renal injury via hypotension or neutrophil activation. Many agents [e.g., mann...

Oct 26th, 2021 - Rationale: The population impact of HIV pre-exposure prophylaxis (PrEP) largely depends on the uptake and consistent use of PrEP by people at high risk for HIV infection. In the Dutch National PrEP Programme (NPP), PrEP care consists of quarterly ...

Oct 18th, 2021 - Background Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a familial cancer syndrome characterized by a propensity for developing renal cancer, and uterine and cutaneous leiomyomas. The kidney cancer associated with HLRCC is clinically...

Oct 8th, 2021 - Our goal for this Learning Healthcare System Demonstration Project is to reduce the rate of inpatient hypoglycemia. Hypoglycemia can result in longer lengths of stay and increased morbidity and mortality (ie falls and cardiovascular or cerebral ev...

Oct 6th, 2021 - Edward S. Kim, MD, chair, Department of Solid Tumor Oncology, Levine Cancer Institute, discusses clinical trial eligibility criteria in lung cancer. Kim led a task force that evaluated the impact of eligibility criteria on clinical trial enrollme...

Oct 6th, 2021 - Alexander Kutikov, MD Chief of the Division of Urology and Urologic Oncology Fox Chase Cancer Center Philadelphia, Pennsylvania Although the standard of care for muscle invasive bladder cancer (MIBC) is to remove the entire bladder, in so...

Oct 5th, 2021 - Two indications have been granted by the FDA to the Nectin-4directed antibody, enfortumab vedotin-ejfv (Padcev), marking a shift in the treatment landscape for patients with advanced urothelial carcinoma. The first, a conversion of an accelerated ...

Jul 23rd, 2021 - Antibiotic dalbavancin (Dalvance), previously approved to treat bacterial skin infections in adults, received FDA approval for the pediatric population from birth, manufacturer AbbVie said in a press release on Friday. Dalbavancin was described as...

Jul 16th, 2021 - There has been renewed interest in eribulin mesylate (Halaven) following its FDA approval for advanced or unresectable liposarcoma and with the introduction of a growing body of preclinical work suggesting the agent has a novel anti—mesenchymal me...